Diffusion Pharmaceuticals Inc (DFFN)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Diffusion Pharmaceuticals Inc (DFFN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013952
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a drug development company that develops standard-of-care therapies. The company offers new and small-molecule drugs for regulating the movement of oxygen into tissue. It provides therapeutic for life-threatening diseases. Diffusion develops trans sodium crocetinate, a synthetic small molecule that improves the diffusion of oxygen into hypoxic tissue and sensitizes the tumor to radiation therapy. The company offers products for cancer, stroke and heart attack. It performs clinical study on brain metastasis through cancer centers. Diffusion is headquartered in Charlottesville, Virginia, the US.

Diffusion Pharmaceuticals Inc (DFFN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Diffusion Pharma Raises USD3.4 Million in Venture Financing 12
Diffusion Pharma Raises US$10 Million In Venture Financing 13
Diffusion Pharma Raises US$2.2 Million In Venture Financing 14
Merger 15
RestorGenex Merges with Diffusion Pharma 15
Stratus Media Completes Merger With Canterbury Labs And Hygeia Therapeutics 16
Equity Offering 17
Diffusion Pharma Plans to Raise Funds in Secondary Offering of Shares 17
Diffusion Pharma Raises USD9.2 Million in Second and Final Tranche of Private Placement of Series A Preferred Stock 18
Acquisition 20
Stratus Media Acquires Paloma Pharma 20
Diffusion Pharmaceuticals Inc – Key Competitors 21
Diffusion Pharmaceuticals Inc – Key Employees 22
Diffusion Pharmaceuticals Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Nov 13, 2017: Diffusion Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update 24
Aug 14, 2017: Diffusion Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update 26
May 15, 2017: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial First Quarter 2017 Results 28
Mar 31, 2017: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports 2016 Financial Results 29
Nov 14, 2016: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial Third Quarter 2016 Results 30
Aug 15, 2016: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial Second Quarter 2016 Results 31
Aug 15, 2016: Diffusion Pharmaceuticals Appoints Biotech Industry Veteran Isaac Blech to Board of Directors 32
May 16, 2016: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports First Quarter 2016 Results 33
Mar 28, 2016: Diffusion Pharmaceuticals Provides Corporate Highlights and Reports 2015 Financial Results 34
Corporate Communications 35
Aug 23, 2017: Diffusion Pharmaceuticals Names William Hornung Chief Business Officer 35
Jul 06, 2017: Diffusion Pharmaceuticals Appoints Dr. Robert Ruffolo to Board of Directors 36
Product News 37
07/06/2016: Diffusion Pharmaceuticals Announces Acceptance of Abstract on Use of TSC in Hypoxia Driven Medical Emergencies at ACEP 2016 Research Forum 37
05/13/2016: Diffusion Pharmaceuticals Announces Publication of TSC Phase 1/2 Glioblastoma Multiforme Trial Data in the Journal of Neurosurgery 38
03/15/2016: Diffusion Pharmaceuticals Announces Publication of RES-529 Review Article in Anti-Cancer Drugs 39
Clinical Trials 40
Sep 19, 2016: Diffusion Pharmaceuticals Successfully Completes Animal Toxicity Studies in Preparation for Phase 3 Pivotal Trial of TSC in New Diagnosed Glioblastoma Patients 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Diffusion Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Diffusion Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Diffusion Pharma Raises USD3.4 Million in Venture Financing 12
Diffusion Pharma Raises US$10 Million In Venture Financing 13
Diffusion Pharma Raises US$2.2 Million In Venture Financing 14
RestorGenex Merges with Diffusion Pharma 15
Stratus Media Completes Merger With Canterbury Labs And Hygeia Therapeutics 16
Diffusion Pharma Plans to Raise Funds in Secondary Offering of Shares 17
Diffusion Pharma Raises USD9.2 Million in Second and Final Tranche of Private Placement of Series A Preferred Stock 18
Stratus Media Acquires Paloma Pharma 20
Diffusion Pharmaceuticals Inc, Key Competitors 21
Diffusion Pharmaceuticals Inc, Key Employees 22
Diffusion Pharmaceuticals Inc, Subsidiaries 23

★海外企業調査レポート[Diffusion Pharmaceuticals Inc (DFFN)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Futuren (FTRN)-エネルギー分野:企業M&A・提携分析
    Summary Futuren, formerly Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The compa …
  • EBOS Group Ltd (EBO):製薬・医療:M&Aディール及び事業提携情報
    Summary EBOS Group Ltd (EBOS) is a healthcare products supplier that markets, sells and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and med …
  • GMR Infrastructure Limited (GMRINFRA)-エネルギー分野:企業M&A・提携分析
    Summary GMR Infrastructure Limited (GMR), a subsidiary of GMR Enterprises Private Limited, is a holding company which undertakes various projects across airport, energy, transportation and urban infrastructure sectors. The company owns and operates Delhi's Indira Gandhi International Airport, Rajiv …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • AFC Energy plc (AFC):企業の財務・戦略的SWOT分析
    Summary AFC Energy Plc (AFC Energy) is a developer of alkaline fuel cells. The company's projects include Power-Up and Alkammonia. AFC Energy power generation technology is used in the industrial markets and produces heat, water, and electricity. The company provides its electricity for industrial a …
  • The Siam Cement Public Co Ltd:企業の戦略・SWOT・財務情報
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Comision Federal de Electricidad-エネルギー分野:企業M&A・提携分析
    Summary Comision Federal de Electricidad (CFE) is a Mexican state owned power utility. It carries out the generation, transmission, distribution, supply and commercialization of electricity. The company generates electricity through various energy sources including thermal, hydro, coal-fired, wind, …
  • Vermillion Inc (VRML):医療機器:M&Aディール及び事業提携情報
    Summary Vermillion Inc (Vermillion) is a medical device company that discovers, develops and markets diagnostic and bio-analytical solutions that supports physicians to diagnose, treat and improve gynecologic health outcomes for women. The company’s in vitro diagnostic test OVA1, a simple blood test …
  • MRI Interventions Inc (MRIC):企業の製品パイプライン分析2018
    Summary MRI Interventions Inc (MRI Interventions) is a medical equipment company that develops and commercializes platforms for performing invasive surgical procedures. The company’s products include systems used for performing invasive surgeries on brain and heart. Its products are used for treatin …
  • MAN SE (MAN):企業の財務・戦略的SWOT分析
    MAN SE (MAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Parker Hannifin Corp (PH):企業の財務・戦略的SWOT分析
    Parker Hannifin Corp (PH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • B.P. Marsh & Partners plc (BPM):企業の財務・戦略的SWOT分析
    Summary B.P. Marsh & Partners plc (B.P. Marsh) is a financial service provider that offers venture capital and private equity investments. The company invests in early stage financial services intermediary businesses, including insurance intermediaries, financial advisors, wealth and fund managers a …
  • Access Bio Inc (950130):医療機器:M&Aディール及び事業提携情報
    Summary Access Bio Inc (Access Bio) is a medical device company that research, develops, manufactures and markets in-vitro diagnostics tests, biosensor, and molecular diagnostic products. The company provides in vitro diagnostic technology such as immunochemical, biochemical and molecular products. …
  • Bloomin’ Brands Inc:企業の戦略・SWOT・財務分析
    Bloomin' Brands Inc - Strategy, SWOT and Corporate Finance Report Summary Bloomin' Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vietnam Export Import Commercial Joint Stock Bank
    Vietnam Export Import Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report Summary Vietnam Export Import Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Hong Kong Aircraft Engineering Co. Ltd:企業の戦略・SWOT・財務情報
    Hong Kong Aircraft Engineering Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary Hong Kong Aircraft Engineering Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • East-Central Iowa Rural Electric Cooperative:発電所・企業SWOT分析
    East-Central Iowa Rural Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Saladax Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Saladax Biomedical Inc (Saladax) is a medical equipment company that develops diagnostic tests. The company provides products such as My5-FU, MyPaclitaxel, MyImatinib and MyDocetaxel, among others. Its My5-FU measures and helps physicians to optimize a patient’s exposure to 5-fluorouracil, M …
  • Memorial Health System:企業の戦略的SWOT分析
    Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Air India Ltd.:企業の戦略・SWOT・財務分析
    Air India Ltd. - Strategy, SWOT and Corporate Finance Report Summary Air India Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆